A Phase II, Open-Label, Randomized, Parallel-Group Multicenter Trial Comparing Two Schedules of GW572016 as First-Line Monotherapy in Patients With Advanced or Metastatic Breast Cancer
Latest Information Update: 27 Aug 2023
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 04 Nov 2008 Updated from ClinicalTrials.gov record.
- 21 May 2008 Results have been reported (1102280)
- 10 Aug 2007 Status change from in progress to completed